Literature DB >> 2429567

Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis.

D A Warrell, S Looareesuwan, R E Phillips, N J White, M J Warrell, H M Chapel, S Areekul, S Tharavanij.   

Abstract

We tested the hypothesis that cerebral malaria is caused by blood-brain barrier inflammation and cerebral edema. In a group of 157 Thai patients with strictly defined cerebral malaria, cerebrospinal fluid (CSF) opening pressures were normal in 79% and were lower in fatal cases than in survivors (means +/- 1 SD, 144 +/- 58 and 167 +/- 51 mm CSF, respectively, P = 0.051). CSF: serum albumin ratios (X 10(3)) in 39 of them were significantly higher than in 61 British controls (medians 8.5 and 5.5, respectively, P = 0.04), but were no higher in 7 fatal cases. In a group of 12 patients this ratio was not significantly higher during coma than after full recovery (means +/- 1 SD, 9.0 +/- 6.2 and 6.7 +/- 4.2, respectively, P greater than 0.1). CSF alpha 2-macroglobulin concentrations were always normal. CSF : serum 77Br- ratios were elevated in 11/19 comatose cases but fell to normal 4 to 9 days later in 11/11 cases. Dexamethasone treatment had no significant effect on bromide partition. The percentage of an intravenously administered dose of 125I-human serum albumin detectable per ml of CSF 6 hr after intravenous injection was 2.4 +/- 1.3 X 10(-5) in 14 comatose patients and 4.4 +/- 4.0 X 10(-5) in 9 of them during convalescence (P greater than 0.1). These results demonstrate that the blood-CSF barrier is essentially intact in patients with cerebral malaria and give no support to the idea that cerebral edema is the cause of coma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429567     DOI: 10.4269/ajtmh.1986.35.882

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Is ischemia involved in the pathogenesis of murine cerebral malaria?

Authors:  L A Sanni; C Rae; A Maitland; R Stocker; N H Hunt
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 2.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 3.  Dynamic interactions of Plasmodium spp. with vascular endothelium.

Authors:  Mark R Gillrie; May Ho
Journal:  Tissue Barriers       Date:  2016-12-07

4.  Cerebral edema and cerebral hemorrhages in interleukin-10-deficient mice infected with Plasmodium chabaudi.

Authors:  Latifu A Sanni; William Jarra; Ching Li; Jean Langhorne
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Severe falciparum malaria (21 cases).

Authors:  F Salord; B Allaouchiche; P Gaussorgues; A Boibieux; M Sirodot; M Gerard-Boncompain; F Biron; D Peyramond; D Robert
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

6.  Intrathecal immunoglobulin synthesis in cerebral malaria.

Authors:  H M Chapel; D A Warrell; S Looareesuwan; N J White; R E Phillips; M J Warrell; V Supawanta; S Tharavanij
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

Review 7.  Severe malaria: what's new on the pathogenesis front?

Authors:  Samuel Crocodile Wassmer; Georges Emile Raymond Grau
Journal:  Int J Parasitol       Date:  2016-09-23       Impact factor: 3.981

8.  Cerebrospinal Fluid Studies in Kenyan Children with Severe Falciparum Malaria.

Authors:  N Mturi; G Keir; C A Maclennan; A Ross; A C Willis; B C Elford; J A Berkley; C R J C Newton
Journal:  Open Trop Med J       Date:  2008

9.  Malarial retinopathy in Bangladeshi adults.

Authors:  Abdullah Abu Sayeed; Richard J Maude; Mahtab Uddin Hasan; Noor Mohammed; M Gofranul Hoque; Arjen M Dondorp; M Abul Faiz
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

10.  Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children.

Authors:  Fiona E Lovegrove; Noppadon Tangpukdee; Robert O Opoka; Erin I Lafferty; Nimerta Rajwans; Michael Hawkes; Srivicha Krudsood; Sornchai Looareesuwan; Chandy C John; W Conrad Liles; Kevin C Kain
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.